Medical Affairs
U.S. Medical Affairs leverages therapeutic expertise to demonstrate the value of your therapy more effectively.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
WHO WE HELP
-
Pharmaceutical Manufacturers
-
Emerging Biopharma
-
MedTech
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsMedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialty and Patient Advocacy
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSBlog
Driving the Right Stakeholder Dialogue (Part 2 of 5)
Medical Affairs: Identify and Engage the Right Experts at the Right Times
Mar 26, 2024
For Medical Affairs teams, finding and engaging thought leaders and other influencers isn’t as straightforward as in years past. Macro forces — namely, treatment complexity, digital acceleration, and data proliferation — have made it more challenging and more important to identify and engage the right experts at every stage of the product development lifecycle.
In large-molecule spaces or large therapeutic areas, potential targets number in the hundreds or thousands. But with highly novel specialty treatments, the list of potential targets is dramatically shorter. Similarly, it’s a straightforward process to determine which experts are prominent voices in peer-reviewed scientific journals. It's more challenging to surface the impactful voices who provide important messaging to their peers via more informal channels. All the while, life sciences organizations are navigating vast quantities of data from a greater variety of sources.
It adds up to a compelling opportunity for Medical Affairs teams to take a fresh approach to expert identification and engagement. What follows are three hallmarks of such an approach.
Holistic view of experts over time
An expert’s journey is not usually linear. When taking a holistic view, it becomes clear that an expert may be important to engage in different ways at different phases of the product lifecycle. For example, an individual may start the journey as a scientific leader establishing the scientific narrative through publishing, clinical trials, conference activity, and guideline authorship. Then the same expert may play a role in peer leadership by providing trusted treatment advice and guidance to their peers. As the lifecycle progresses, they may eventually transition to clinical leadership as a prolific treater.
Medical Affairs teams have an opportunity to help in identifying these personas and building a strategy for engaging them in appropriate ways at appropriate times. Start by determining key milestones across the product development lifecycle, and then segment experts into core buckets of expertise. Some may be well suited to generating your science, some to validating it. As you move closer to commercialization, there may be another segment well positioned to help disseminate medical information across the learning networks of other healthcare providers. Post-launch, experts may play a role in leading scientific conversations within digital and social channels.
Unified data and technology foundation
Achieving this holistic view of experts requires a wealth of data beyond traditional scientific or clinical data. Look not only to digital data, but also to claims data for understanding diagnostic and treatment leadership, along with data gathered through primary research.
Unfortunately, many organizations are still operating with fragmented and incomplete information — usually resulting from a disconnected technology infrastructure, a disparate partner ecosystem, or both.
The solution is to create a single environment for integrating and analyzing previously disparate data. Having a single infrastructure simplifies the steps that underpin a holistic view of experts: identifying and profiling, segmenting, and even surfacing insights at the individual level. Having a unified system also helps in executing engagements and measuring their effectiveness.
Connected, readily accessible expert data — powered by a unified technology infrastructure — is the foundation for next-generation engagement.
Precision analytics for finding ‘hidden’ experts
Medical Affairs teams typically have a set of expert personas and identification characteristics, such as scientific presence or treating and referral volume. These traditional frameworks overlook a critical cohort: the “hidden” regional and local leaders who are educating their peers and ultimately driving treatment and behavior change at the community level.
Surveys of the most relevant healthcare providers help to identify the experts they seek out for medical education and clinical advice about a specific indication. Using these known relationships as a starting point — and with a unified data and tech foundation — it becomes possible to predict peer learning relationships and networks for the entire U.S. market. In fact, IQVIA has a patented, innovative artificial intelligence machine learning (AI/ML) modeling process, which produces these unique market insights.
Start building better strategies for expert identification and engagement
Gone are the days of focusing solely on nationally known scientific leaders and high-volume treaters. While those audiences remain valuable, Medical Affairs teams and their commercial colleagues must complement them by engaging the larger, more nuanced chorus of local and regional peer leaders and their learning networks. When you can create a 360-degree view of an expert and each role they play in the market, you unlock more granular profiling and segmentation — while enabling a more holistic view of expert engagement across your product’s lifecycle.
In case you missed it, click here to read the previous blog in this series.
Unlock Excellence in Medical Affairs
At IQVIA, we partner with you to navigate your strategic Medical Affairs journey, utilizing trusted medical evidence from clinical development through commercialization.
Discover how IQVIA Medical Affairs can elevate your impact and advance healthcare decision-making.
Related solutions
Real World Evidence
Meet your clinical, economic, and regulatory needs throughout a product's lifecycle using U.S. real world solutions.
Real World Evidence
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.